Role of CD4+ T lymphocytes in antitumor immunity.
Rajnavölgyi
Eva
E
Institute of Immunology, Medical and Health Science Center, Faculty of Medicine, University of Debrecen, Debrecen H-4012, Hungary.
Lányi
Arpád
A
D000938:Antigen-Presenting Cells / Q000276:immunology / Q000473:pathology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use; D003713:Dendritic Cells / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods / Q000639:trends; D008213:Lymphocyte Activation; D009369:Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D016176:T-Lymphocyte Subsets / Q000276:immunology
D019496:Cancer Vaccines